Home Evaluation of STroke Induced Aid "HESTIA"


Phase N/A Results

Trial Description

To determine whether a home-nursing-care program positively affects recently-discharged stroke patients' quality of life and satisfaction with their medical care.


Trial Design

Multicenter, randomized, controlled trial.

Patient Involvement

Eligible patients will be randomized to receive either standard care alone, or standard care in combination with a home-nursing-care program. Six stroke nurses will contact the patients in the home-care cohort by telephone at 1-3 weeks, 4-6 weeks, and 18-22 weeks after discharge, and by a home visit 10-12 weeks after discharge. During all contacts, the nurse will describe poststroke care, providing information concerning stroke diagnosis, the consequences of stroke, and secondary prevention. Patients' primary caregivers will also be interviewed and educated at these sessions. Any problems perceived by the patient or the primary caregiver, as well as interventions carried out by the nurse will be recorded. Patients in both the home-care and the control groups will be evaluated at 6 months post-discharge.


Type Measure Time Frame Safety Issue
Primary Quality of life, assessed with the Short Form-36 Health Survey (SF-36), and satisfaction with care at 6 months.
Secondary Mood, assessed by the Hospital Anxiety and Depression Scale (HADS), quality of life, determined by EuroQol, disability, measured by Barthel Index (BI) and Rankin scores, use of health services, compliance with secondary-prevention drugs, number of unmet healthcare demands, number of hospital readmission days, number of contacts with general practitioners or paramedics, knowledge about stroke, social support, and caregiver stress, measured by the Caregiver Strain Index (CSI) and the Sense of Competence Questionnaire (SCQ).


The Netherlands Heart Foundation, The Netherlands Organization for Scientific Research, and the University Medical Center Utrecht